Literature DB >> 15135698

Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study).

Howard A Cooper1, Dennis A Bloomfield, David E Bush, Michael S Katcher, Michele Rawlins, Joseph D Sacco, Mary Chandler.   

Abstract

Many patients with atrial fibrillation (AF) are treated with rate control and anticoagulation. However, the relation between the degree of heart rate (HR) control and clinical outcome is uncertain. We assessed whether lower achieved HR at rest and/or lower achieved exercise HR was associated with improved prognosis, quality of life (QoL), and functional status among patients in the AFFIRM study. Patients in the rate control arm and who were in AF at baseline and 2 months were included. Patients were grouped by quartile of achieved HR at rest (44 to 69, 70 to 78, 79 to 87, 88 to 148 beats/min) and achieved exercise HR following a 6-minute walk (53 to 82, 83 to 92, 93 to 106, 107 to 220 beats/min). QoL measurements and functional status were also analyzed. Complete data were available for 680 patients for achieved HR at rest, 349 patients for achieved exercise HR, and 118 patients for QoL. Survival free from cardiac hospitalization and overall survival were not significantly different among quartiles of achieved HR at rest (p = 0.19 and p = 0.8, respectively) or achieved exercise HR (p = 0.77 and p = 0.14, respectively). After controlling for covariates, there remained no significant relation between either achieved HR at rest or achieved exercise HR and event-free survival (hazard ratio 0.95, p = 0.35 and hazard ratio 0.98, p = 0.81) or overall survival (hazard ratio 1.03, p = 0.70 and hazard ratio 1.22, p = 0.13). Furthermore, there was no significant association between achieved HR and QoL measurements, New York Heart Association functional class, or 6-minute walking distance. After 2 months of drug titration, neither achieved HR at rest nor achieved exercise HR predicted survival free from cardiovascular hospitalization, overall survival, QoL, or functional status among patients with AF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135698     DOI: 10.1016/j.amjcard.2004.01.069

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

Review 1.  Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.

Authors:  Vincent E Hagens; Dirk J Van Veldhuisen; Harry J G M Crijns; Isabelle C van Gelder
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

Review 2.  Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.

Authors:  F De Rienzo; R R Gabdoulline; R C Wade; M Sola; M C Menziani
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

Review 3.  Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.

Authors:  Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

Review 4.  Rate control in the medical management of atrial fibrillation.

Authors:  A J Camm; I Savelieva; G Y H Lip
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

5.  Rate control in permanent atrial fibrillation.

Authors:  Theodora Nikolaidou; Kevin S Channer
Journal:  BMJ       Date:  2007-11-24

6. 

Authors: 
Journal:  Neth Heart J       Date:  2004-08       Impact factor: 2.380

Review 7.  Rate Control in Atrial Fibrillation: Avoiding Morbidity.

Authors:  Thomas D Callahan
Journal:  J Atr Fibrillation       Date:  2012-12-16

8.  Advances in the Pharmacologic Management of Atrial Fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Card Electrophysiol Clin       Date:  2011-03

9.  Rate control in atrial fibrillation, insight into the RACE II study.

Authors:  H F Groenveld; H J G M Crijns; J G P Tijssen; M Alings; H L Hillege; Y S Tuininga; M P Van den Berg; D J Van Veldhuisen; I C Van Gelder
Journal:  Neth Heart J       Date:  2013-04       Impact factor: 2.380

Review 10.  Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.

Authors:  Harry J G M Crijns
Journal:  Drugs       Date:  2005       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.